National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2023 (No. 8) (Cth)

PB 92 of 2023

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2023
(No. 8)

National Health Act 1953

I, NIKOLAI TSYGANOV, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated               28 September 2023                          

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments  2

National Health (Pharmaceutical benefits—early supply) Instrument 2015
(PB 120 of 2015).   2

1. Name

(1)This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2023 (No. 8).

(2)This instrument may also be cited as PB 92 of 2023.

1. Commencement

(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	1 October 2023	1 October 2023

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

1. Authority

This instrument is made under subsection 84AAA(2) of the National Health Act 1953.

4        Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

1. Schedule 1, after entry for Bictegravir with emtricitabine with tenofovir alafenamide

insert:

Bimekizumab	Injection 160 mg in 1 mL single use pre-filled pen	20	2	2
20	2	4

1. Schedule 1, after entry for Desvenlafaxine in the form Tablet (modified release) 100 mg (as benzoate)

insert:

Deucravacitinib Tablet 6 mg 20 28 5

1. Schedule 1, entry for Insulin aspart

substitute:

Insulin aspart	Injection (human analogue) 100 units per mL, 10 mL vial	20	5	2
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5	20	5	1
Injections (human analogue) (fast acting), cartridges, 100 units per mL, 3 mL, 5	20	5	1

1. Schedule 1, entry for Pirfenidone

omit:

Capsule 267 mg 20 270 5